<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

	<!-- RSS feed defaults -->
	<channel>
		<title>Wyss InstituteKidney Disease &#8211; Wyss Institute</title>
		<link>https://wyss.stage.a17.io</link>
		<description>Wyss Institute at Harvard</description>
		<lastBuildDate>Thu, 30 Jul 2026 21:38:59 +0000</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
		<atom:link href="https://wyss.stage.a17.io/application-area/kidney-disease/feed/" rel="self" type="application/rss+xml" />

		<generator>https://wordpress.org/?v=6.9.6</generator>

		<!-- Start loop -->
		
			<item>
				<title>Innovative tissue engineering: ESCAPE, a pioneering new method explained</title>
				<link>https://wyss.stage.a17.io/news/innovative-tissue-engineering-escape-a-pioneering-new-method-explained/</link>
        <pubDate>Wed, 11 Dec 2024 16:00:31 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Boston University]]></category>
		<category><![CDATA[Christopher Chen]]></category>
		<category><![CDATA[Heart]]></category>
		<category><![CDATA[Implants]]></category>
		<category><![CDATA[Vasculature]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=41664</guid>
                            <description>Molding complex tissues using gallium</description>
                                        <content:encoded><![CDATA[<p>By Boston University Communications (BOSTON) &mdash; When it comes to the human body, form and function work together. The shape and structure of our hands enable us to hold and manipulate things. Tiny air sacs in our lungs called alveoli allow for air exchange and help us breath in and out. And tree&#x2d;like blood vessels branch throughout our body, delivering oxygen from our head to our toes.</p>
<p><a href="https://wyss.stage.a17.io/news/innovative-tissue-engineering-escape-a-pioneering-new-method-explained/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/innovative-tissue-engineering-escape-a-pioneering-new-method-explained/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/12/10165502/12_Cast-with-ring_CROP.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=973cd27dff9e57118ca795750c18a7fa"/></url>
				</image>
        			</item>

		
			<item>
				<title>ESCAPE Bioengineering</title>
				<link>https://wyss.stage.a17.io/media-post/escape-bioengineering/</link>
        <pubDate>Wed, 11 Dec 2024 16:00:06 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Boston University]]></category>
		<category><![CDATA[Christopher Chen]]></category>
		<category><![CDATA[Heart]]></category>
		<category><![CDATA[Implants]]></category>
		<category><![CDATA[Vasculature]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=41676</guid>
                                                <content:encoded><![CDATA[<p>A research team at the Wyss Institute and Boston University has developed ESCAPE, the first method that enables the engineering of tissues across multiple length scales, ranging from the diameter of a cell to the cm scale of a heart valve. Credit: Wyss Institute at Harvard University&#8230;</p>
<p><a href="https://wyss.stage.a17.io/media-post/escape-bioengineering/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/media-post/escape-bioengineering/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/12/11082233/THUMBNAIL_Escape-Bioengineering_No-Text.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=3670be8864105a406ec4c303a084839d"/></url>
				</image>
        			</item>

		
			<item>
				<title>CRISPR&#8217;s Impact, Today</title>
				<link>https://wyss.stage.a17.io/news/crisprs-impact-today/</link>
        <pubDate>Mon, 21 Oct 2024 12:00:08 +0000</pubDate>
        <dc:creator><![CDATA[Mariel Schoen]]></dc:creator>
        		<category><![CDATA[Translation News]]></category>
		<category><![CDATA[CRISPR]]></category>
		<category><![CDATA[Editas Inc.]]></category>
		<category><![CDATA[eGenesis]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Massachusetts General Hospital]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=40926</guid>
                            <description>Keeping CRISPR’s promise for patients in need</description>
                                        <content:encoded><![CDATA[<p>By Seth Kroll (BOSTON) &mdash; In the not&#x2d;so&#x2d;distant past, CRISPR, the revolutionary gene&#x2d;editing technology, was discovered as a defense system protecting bacteria against viruses. Today, with the persistence and ingenuity of many scientists, it is no longer just the subject of fascinating academic research papers and speculative discussions on its future usefulness for medicine.</p>
<p><a href="https://wyss.stage.a17.io/news/crisprs-impact-today/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/crisprs-impact-today/</link>
          <title>Slayman with (left to right) Dr. Leo Riella, Medical Director of Kidney Transplantation, Dr. Nahel Elias, Interim Chief, Division of Transplant Surgery, his partner, Faren, and Dr. Tatsuo Kawai, Director, Legorreta Center for Clinical Transplant Tolerance. CREDITS: Michelle Rose/Massachusetts General Hospital</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/09/09093712/20240403_mcr_transplant_patient_010-1.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=911871f7428259dbd6ffadedb29de92e"/></url>
				</image>
        			</item>

		
			<item>
				<title>Wyss Institute promotes Natalie Artzi to its Core Faculty and appoints Di Feng as an Associate Faculty member</title>
				<link>https://wyss.stage.a17.io/news/wyss-institute-promotes-natalie-artzi-to-its-core-faculty-and-appoints-di-feng-as-an-associate-faculty-member/</link>
        <pubDate>Mon, 12 Aug 2024 13:15:25 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Beth Israel Deaconess Medical Center]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Brain]]></category>
		<category><![CDATA[Brigham and Women's Hospital]]></category>
		<category><![CDATA[Di Feng]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Natalie Artzi]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=40759</guid>
                            <description>Artzi’s promotion and Feng’s appointment strengthen the Institute’s efforts in nanomedicine and immunoengineering, as well as modeling of chronic kidney diseases</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Natalie Artzi, Ph.D., joined the ranks of the Wyss Institute&rsquo;s now 12 Core Faculty members after only two years as an Associate Faculty member. Artzi&rsquo;s promotion reflects her exceptional commitment to the Institute&rsquo;s mission and the deep engagements and collaborations she has initiated within its technology development community. The Wyss Institute also warmly&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/wyss-institute-promotes-natalie-artzi-to-its-core-faculty-and-appoints-di-feng-as-an-associate-faculty-member/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/wyss-institute-promotes-natalie-artzi-to-its-core-faculty-and-appoints-di-feng-as-an-associate-faculty-member/</link>
          <title>In August, we announced <a href="https://wyss.harvard.edu/news/wyss-institute-promotes-natalie-artzi-to-its-core-faculty-and-appoints-di-feng-as-an-associate-faculty-member/">Natalie Artzi’s promotion to Core Faculty member and the appointment of Di Feng</a> as an Associate Faculty member. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/08/08145256/ArtziFengComposite.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=1c298d6dde25ec80aa1f9fe30f99b0fd"/></url>
				</image>
        			</item>

		
			<item>
				<title>Alex Plesa on Reversing Aging</title>
				<link>https://wyss.stage.a17.io/news/humans-of-the-wyss-alex-plesa-on-reversing-aging/</link>
        <pubDate>Thu, 30 May 2024 13:00:18 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Cardiovascular Dysfunction]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Humans of the Wyss]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=40026</guid>
                                                <content:encoded><![CDATA[<p>The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Most people believe that declining health as we age is an unfortunate, inevitable fact of life &ndash; but not Alex Plesa. He thinks the reason we think we can&rsquo;t change it is because we don&rsquo;t&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/humans-of-the-wyss-alex-plesa-on-reversing-aging/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/humans-of-the-wyss-alex-plesa-on-reversing-aging/</link>
          <title>Alex Plesa, Postdoctoral Fellow. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/05/28094559/Alex-Plesa-07200.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=811e245d112be9f293681e9a1f16b2a5"/></url>
				</image>
        			</item>

		
			<item>
				<title>In a first, genetically edited pig kidney is transplanted into human</title>
				<link>https://wyss.stage.a17.io/news/in-a-first-genetically-edited-pig-kidney-is-transplanted-into-human/</link>
        <pubDate>Fri, 22 Mar 2024 21:16:08 +0000</pubDate>
        <dc:creator><![CDATA[Mariel Schoen]]></dc:creator>
        		<category><![CDATA[Translation News]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Massachusetts General Hospital]]></category>
		<category><![CDATA[Organ Engineering]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=39524</guid>
                            <description>Procedure marks milestone in quest to provide more organs to patients in need</description>
                                        <content:encoded><![CDATA[<p>By Mass General Brigham Communications In a first&#x2d;of&#x2d;its&#x2d;kind medical procedure, Harvard Medical School physician&#x2d;scientists at Massachusetts General Hospital have transplanted a genetically edited pig kidney into a human. While many unknowns remain about the viability of the newly transplanted organ and the patient&rsquo;s long&#x2d;term health, the procedure &mdash; made possible in part by scientific&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/in-a-first-genetically-edited-pig-kidney-is-transplanted-into-human/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/in-a-first-genetically-edited-pig-kidney-is-transplanted-into-human/</link>
          <title>Surgeons transplant the pig kidney. “It was truly the most beautiful kidney I have ever seen,” said team co-lead Tatsuo Kawai (center). Credit: Massachusetts General Hospital</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/03/22171527/MGH-surgery.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=941fb66a7b55642ca829c70f087ed9d2"/></url>
				</image>
        			</item>

		
			<item>
				<title>Adding immunity to human kidney-on-a-chip advances cancer drug testing</title>
				<link>https://wyss.stage.a17.io/news/adding-immunity-to-human-kidney-on-a-chip-advances-cancer-drug-testing/</link>
        <pubDate>Wed, 23 Aug 2023 14:57:37 +0000</pubDate>
        <dc:creator><![CDATA[Seth Kroll]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Cell Engineering]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Inflammation]]></category>
		<category><![CDATA[Jennifer A. Lewis]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=37512</guid>
                            <description>An immune-infiltrated human kidney organoid-on-chip model enables assessment of kidney toxicities to immunotherapeutic T cell bispecific antibody drugs with high resolution</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (Boston) &mdash; A growing repertoire of cell and molecule&#x2d;based immunotherapies is offering patients with indomitable cancers new hope by mobilizing their immune systems against tumor cells. An emerging class of such immunotherapeutics, known as T cell bispecific antibodies (TCBs), are of growing importance with several TCBs that the U.S. Food and Drug Administration (FDA)&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/adding-immunity-to-human-kidney-on-a-chip-advances-cancer-drug-testing/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/adding-immunity-to-human-kidney-on-a-chip-advances-cancer-drug-testing/</link>
          <title>The team’s study demonstrated in a novel immune-infiltrated human kidney organoid-on-chip model that a T cell bispecific antibody (TCB) targeting an antigen from the Wilms tumor-1 protein (WT1-TCB) specifically recruits immune cells, including cytotoxic T cells (shown in green), to clusters of podocytes (shown in blue), leading to their destruction. The grey staining is derived from dying cells. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2023/08/22163738/Kidney-organoid-on-chip.jpeg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=d47559348b52211470cb82f9a9d11ed3"/></url>
				</image>
        			</item>

		
			<item>
				<title>Harvard Wyss Institute’s eRapid multiplexed biosensor technology licensed to StataDX to enable new diagnostics for neurological, cardiovascular, and renal diseases</title>
				<link>https://wyss.stage.a17.io/news/harvard-wyss-institutes-erapid-multiplexed-biosensor-technology-licensed-to-statadx-to-enable-new-diagnostics-for-neurological-cardiovascular-and-renal-diseases/</link>
        <pubDate>Mon, 27 Jun 2022 12:58:22 +0000</pubDate>
        <dc:creator><![CDATA[Mariel Schoen]]></dc:creator>
        		<category><![CDATA[Translation News]]></category>
		<category><![CDATA[Anti-fouling]]></category>
		<category><![CDATA[Biosensors]]></category>
		<category><![CDATA[Blood]]></category>
		<category><![CDATA[Cardiovascular Dysfunction]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Neurology]]></category>
		<category><![CDATA[Technology Translation]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=32858</guid>
                            <description>The startup will develop and commercialize cost-effective, highly sensitive and specific point-of-care diagnostics, applying a novel electrochemical sensor platform created at the Wyss Institute</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Today the Wyss Institute for Biologically Inspired Engineering at Harvard University and Cambridge&#x2d;based StataDX Inc. announced that the Wyss Institute&rsquo;s affinity&#x2d;based, multiplexed, electrochemical sensing technology, eRapid, has been licensed to the startup. The license, coordinated by Harvard&rsquo;s Office of Technology Development (OTD)&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/harvard-wyss-institutes-erapid-multiplexed-biosensor-technology-licensed-to-statadx-to-enable-new-diagnostics-for-neurological-cardiovascular-and-renal-diseases/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/harvard-wyss-institutes-erapid-multiplexed-biosensor-technology-licensed-to-statadx-to-enable-new-diagnostics-for-neurological-cardiovascular-and-renal-diseases/</link>
          <title>This photo shows the Wyss Institute’s team that developed the eRapid electrochemical biosensor technology. Shown from left to right are: Sanjay Sharma Timilsina, Ph.D., former Postdoctoral Fellow on the team; Pawan Jolly, Ph.D., Wyss Senior Staff Scientist; Donald Ingber, M.D., Ph.D., Wyss Founding Director; and Nolan Durr, former Wyss Research Assistant. Research engineers Timilsina and Durr are joining StataDX, which was co-founded by Jolly and Ingber together with external co-founders Sidhant Jena, CEO, and Michal Depa, CTO. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2022/06/21153533/eRapid-Team-Photo-with-Don-Ingber.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=732422f71b79868e3042868d92cc86be"/></url>
				</image>
        			</item>

		
			<item>
				<title>Harvard University licenses kidney engineering technology to Trestle Biotherapeutics to facilitate new kidney replacement therapies</title>
				<link>https://wyss.stage.a17.io/news/harvard-university-licenses-kidney-engineering-technology-to-trestle-biotherapeutics-to-facilitate-new-kidney-replacement-therapies/</link>
        <pubDate>Tue, 22 Feb 2022 18:57:14 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Translation News]]></category>
		<category><![CDATA[3D Bioprinting]]></category>
		<category><![CDATA[Brigham and Women's Hospital]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Jennifer A. Lewis]]></category>
		<category><![CDATA[Technology Translation]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=31690</guid>
                            <description>Powerful combination of 3D bioprinting and stem cell-based tissue engineering could enable new approaches to treating chronic kidney disease</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON/CAMBRIDGE, Mass.) &mdash; A newly launched startup is building upon innovations developed over several years at the Wyss Institute for Biologically Inspired Engineering at Harvard University, Harvard John A. Paulson School of Engineering &amp; Applied Sciences (SEAS), and Brigham and Women&rsquo;s Hospital (Brigham) to engineer functional kidney tissue for renal repair and&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/harvard-university-licenses-kidney-engineering-technology-to-trestle-biotherapeutics-to-facilitate-new-kidney-replacement-therapies/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/harvard-university-licenses-kidney-engineering-technology-to-trestle-biotherapeutics-to-facilitate-new-kidney-replacement-therapies/</link>
          <title>JThis image shows a kidney organoid (blue) embedded with vascular channels (red). Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2022/02/18130445/Vascularized-kidney-organoid-1.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=f56937666af30e9e5d9f497a9e778161"/></url>
				</image>
        			</item>

		
			<item>
				<title>Interrogator: Human Organ-on-Chips</title>
				<link>https://wyss.stage.a17.io/media-post/interrogator-human-organ-on-chips/</link>
        <pubDate>Mon, 27 Jan 2020 16:00:40 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Biomimetic Microsystems]]></category>
		<category><![CDATA[DARPA]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Emulate Inc.]]></category>
		<category><![CDATA[Gut-on-a-Chip]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Heart-on-a-Chip]]></category>
		<category><![CDATA[Kevin Kit Parker]]></category>
		<category><![CDATA[Liver-on-a-Chip]]></category>
		<category><![CDATA[Vasculature]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=23307</guid>
                                                <content:encoded><![CDATA[<p>This video describes the &ldquo;Interrogator&rdquo; instrument that can be programmed to culture up to 10 different Organ Chips and sequentially transfer fluids between their vascular channels to mimic normal human blood flow between the different organs of our body. Its integrated microscope enables the continuous monitoring of the tissues&rsquo; integrities in the individual organ chips in long&#x2d;term studies.</p>
<p><a href="https://wyss.stage.a17.io/media-post/interrogator-human-organ-on-chips/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/media-post/interrogator-human-organ-on-chips/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2020/01/27105238/THUMBNAIL_Interrogator-Human-Organ-on-Chips_NO-TEXT.png?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=5ce6699cb1cd7c6c3e3b92ca190ae9ab"/></url>
				</image>
        			</item>

			</channel>
</rss>
